In vitro activity of antimitotic compounds against the microsporidium Encephalitozoon intestinalis.
Amara
M O
MO
Inserm U 511, Immunobiologie cellulaire et Moléculaire des Infections Parasitaires, CHU Pitié-Salpêtrière, Paris, France.
Franetich
J F
JF
Bouladoux
N
N
Mazier
D
D
Eisenbrand
G
G
Marko
D
D
Meijer
L
L
Doerig
C
C
Desportes-Livage
I
I
D047151:Amaryllidaceae Alkaloids; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001533:Belladonna Alkaloids / Q000494:pharmacology*; D002460:Cell Line; D016819:Encephalitozoon / Q000187:drug effects* / Q000254:growth & development / Q000648:ultrastructure; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D020128:Inhibitory Concentration 50; D008854:Microscopy, Electron; D021261:Parasitic Sensitivity Tests; D010617:Phenanthridines / Q000494:pharmacology*; D011817:Rabbits; D012266:Ribose / Q000737:chemistry; D019311:Staurosporine / Q000737:chemistry
D047151:Amaryllidaceae Alkaloids; D000970:Antineoplastic Agents; D001533:Belladonna Alkaloids; D004791:Enzyme Inhibitors; D010617:Phenanthridines; D012266:Ribose; D019311:Staurosporine; C015330:lycorine